Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer-Reference-Cited by-同舟云学术

Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer

Published:2009-05-20 Issue:3 Volume:120 Page:567-579
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Karn Thomas,Metzler Dirk,Ruckhäberle Eugen,Hanker Lars,Gätje Regine,Solbach Christine,Ahr Andre,Schmidt Marcus,Holtrich Uwe,Kaufmann Manfred,Rody Achim

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-009-0416-z.pdf

Reference66 articles.

1. Coates A, Goldhirsch A, Gelber R, International Breast Cancer Study Group (2002) Overhauling the breast cancer overview: are subsets subversive? Lancet Oncol 3(9):525–526. doi: 10.1016/S1470-2045(02)00842-2

2. Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A (2001) Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet 358(9278):277–286. doi: 10.1016/S0140-6736(01)05483-6

3. Sylvester R, Collette L, Duchateau L (2000) The role of meta-analyses in assessing cancer treatments. Eur J Cancer 36(11):1351–1358. doi: 10.1016/S0959-8049(00)00125-8

4. Ein-Dor L, Zuk O, Domany E (2006) Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 103(15):5923–5928. doi: 10.1073/pnas.0601231103

5. Cheadle C, Vawter MP, Freed WJ, Becker KG (2003) Analysis of microarray data using Z score transformation. J Mol Diagn 5(2):73–81

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Annotated Compendium of 102 Breast Cancer Gene-Expression Datasets;2023-09-24

2. Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy;Cancers;2023-04-07

3. Molecular differences between younger versus older ER-positive and HER2-negative breast cancers;npj Breast Cancer;2022-11-07

4. Enhanced Directed Random Walk for the Identification of Breast Cancer Prognostic Markers from Multiclass Expression Data;Entropy;2021-09-20

5. Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy;Annals of Oncology;2021-05